Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Klein, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klein, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Treatment patterns in stable angina: objectives and reality

W. Klein*

University Hospital Graz, Graz, Austria

* Correspondence: Werner W. Klein, Medizinische Universitäsklinik, Klinische Abteilung für Kardiologie, Auenbruggerplatz 15, A-8036 Graz, Austria.

Abstract

The aims of treatment for stable angina are to improve symptoms and quality of life, to prevent cardiovascular events and to prolong life. According to current guidelines, such patients require risk factor modification, education and pharmacological treatment with beta-blockers, calcium channel blockers and nitrates, with cardioprotection with aspirin, lipid-lowering drugs and angiotensin-converting enzyme inhibitors. Despite this treatment, approximately one-third of patients do not become free of angina. Various combinations of haemodynamic agents did not demonstrate significant superior efficacy in terms of exercise test parameters. Therefore, there is a strong rationale for using new combined therapeutic approaches, including metabolic drugs such as trimetazidine. As yet, there is no evidence of an effect on the progression of atherosclerotic disease or morbidity or mortality with our treatment approach. A new epidemiological survey (Angina Treatment Pattern Survey) will be carried out in several countries. This survey is designed to characterize the angina patient population to describe current practice, and to evaluate the efficacy and limits of current management.

Key Words: Ischaemia • pharmacotherapy • stable angina • trimetazidine

References

  1. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM Guidelines for the Management of Patients with Chronic Stable Angina. J Am Coll Cardiol. 1999;33:2092–2097[Free Full Text]
  2. Heart Outcome Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med. 2000;342:145–153[Abstract/Free Full Text]
  3. Task Force of the European Society of Cardiology. Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 1997;18:394–413[Free Full Text]
  4. Haiat R, Leroy G. Cardiovascular Therapeutics: Cross-sectional Analysis of Major Clinical Trials. Paris: Editions Frison-Roche; 1999.
  5. Akhras K, Burch S, Dedhiya S, Sood S. Health-related quality of life in the treatment of angina. Heart Dis. 2000;2:201–206[Medline]
  6. Michaelides AP, Spiropoulos K, Dimopoulos K, Athanasiades D, Toutouzas P. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina. Clin Drug Invest. 1997;13:8–14
  7. Dargie JH, Ford I, Fox KM, Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR, and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J. 1996;17:104–112[Abstract/Free Full Text]
  8. Rehnqvist N, Hjemdahl P, Billing E et al. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS Study. Angina Prognosis Study in Stockholm. Cardiologia 195; 40(suppl 1):301.
  9. Von Arnim T. Medical treatment to reduce total ischemic burden: total ischemic burden study bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS investigators. J Am Coll Cardiol. 1995;25:231–238[Abstract]
  10. Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1996;27:311–316[Abstract]
  11. Pepine CJ, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation. 1994;90:762–768[Abstract/Free Full Text]
  12. Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation. 2000;102:1503–1510[Abstract/Free Full Text]
  13. Blumenthal RS, Cohn G, Schulman SP. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J Am Coll Cardiol. 2000;36:668–673[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Klein, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klein, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?